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A technique for separating and detecting enzyme inhibitors was developed using capillary 
electrophoresis with an enzyme microreactor. The on-column enzyme microreactor was 
constructed using one or two NdFeB magnets in two configurations to immobilize alkaline 
phosphatase-coated superparamagnetic beads with diameters of 2.8 µm inside a capillary before 
the detection window. Enzyme inhibition assays were performed by injecting a plug of inhibitor 
into a capillary filled with an alkaline phosphatase substrate, AttoPhos. Product generated in the 
enzyme microreactor was detected by laser-induced fluorescence. Inhibitor zones 
electrophoresed through the capillary, passed through the enzyme microreactor, and were 
observed as negative peaks due to decreased product formation in the presence of the inhibitors. 
The goal of this study was to improve peak capacities for inhibitor separations relative to 
previous work, which combined continuous engagement electrophoretically mediated 
microanalysis (EMMA) and transient engagement EMMA to study enzyme inhibition. The 
effects of electric field strength, bead injection time and inhibitor concentrations on peak 
capacity and peak width were investigated. Increasing the electric field strength from 100 V/cm 
to 500 V/cm caused a 2-3-fold decrease in peak capacity for alkaline phosphatase inhibition 
assays with arsenate, a reversible, competitive inhibitor. When the bead injection time was 
increased to increase the length of the immobilized bead plug, the peak capacity for arsenate 
reached a minimum value at 60.0 s for the one-magnet configuration and at 30.0 s for the two-
magnet configuration. The peak capacity was enhanced to 20 under optimal conditions of electric 
field strength and bead injection time for inhibition assays with arsenate and theophylline. The 
inhibition peak width increased as the concentrations of arsenate and theophylline increased. 
Five reversible inhibitors of alkaline phosphatase (theophylline, orthovanadate, arsenate, L-




technique to analyze complex inhibitor mixtures. A well-resolved, individual inhibition peak was 
observed for each inhibitor. Enzyme inhibition assays with a mixture of the five inhibitors were 
also performed with the previous EMMA method, and a peak capacity of only 3 was obtained 
























CHAPTER 1  
INTRODUCTION  
1.1 Enzyme Assays 
Enzymes are biological catalysts for chemical reactions in all living systems. Like other 
chemical catalysts, enzymes increase the reaction rate by lowering the activation energy [1-7]. 
Protein-based enzymes are the dominant form of biocatalyst. Also, there are a few RNA 
molecules called ribozymes that catalyze fundamental biochemical reactions [1, 4]. Enzymes are 
responsible for enabling the many chemical processes that are taking place at any time in a 
biological cell. Enzyme catalysis has been used by people for thousands of years for 
fermentation in both bread and alcohol production [3, 4]. Enzyme catalysis is now widely used 
for commercial applications. Enzymes are used to prepare fabrics in the textile industry and to 
tan hides in the leather industry [4, 8-10]. Enzymes are used as ingredients in detergents [4, 8, 
11], and have also found various applications in the pulp and paper industry [8, 12]. In addition, 
they play an important role in the production of biofuel from crops such as sugar cane and corn 
[8, 13].  Since enzymes are highly efficient catalysts that work under mild conditions of 
temperature, pH and pressure and are also enantiospecific, they are employed to catalyze the 
syntheses of organic compounds [3, 14]. Moreover, enzymes are the biologically responsive 
material in many biosensors [15, 16]. 
Enzymes have an active site, where the reacting molecule, called the substrate, binds and 
where the chemical reaction occurs. The active site is usually a small pocket on the enzyme 
surface, which contains the binding and catalytic functional groups. The structural and chemical 
properties of the active site make the enzyme specific for only one type of substrate [1, 3-5, 7]. 









In an enzyme-catalyzed reaction, the substrate (S) binds to the active site of the enzyme (E) to 
form an intermediate complex (ES), which proceeds to form product (P) or dissociates back to 
enzyme (E) and substrate (S). With the product (P) being formed, free enzyme (E) molecule is 
released and the catalytic cycle begins again [1, 3-7]. 
A quantitative analysis of enzyme-catalyzed reactions was proposed by Henri (1903) and by 
Michaelis and Menten (1913) [4, 5, 7]. They assumed that k2 << k-1 in the general reaction 
scheme. In the Henri–Michaelis–Menten model, the reversible step between E + S and the ES 
complex reaches equilibrium very rapidly, and the ES complex converts slowly to product (P). A 
more sophisticated and general model was later developed by Briggs and Haldane (1925) based 
on the steady-state approximation [4, 5, 7]. This model does not assume k2 << k-1 and states that 
a steady state arises shortly after the beginning of the enzyme-catalyzed reaction. During the 
period of steady state, the rate of formation of the ES complex is equal to the sum of the rate of 
its dissociation back to substrate (S) and the rate of its transformation to product (P). Therefore, 
the ES concentration is constant. From the steady-state approximation the following rate 
equation, which describes the dependence of the reaction velocity on the substrate concentration, 
can be derived: 











                                                          (1.1) 
This is the basic equation of enzyme kinetics. In honor of the pioneering work of Henri, 
Michaelis and Menten, this equation is commonly referred to as the Michaelis–Menten or Henri–










= −                                                        (1.2) 
Km represents the substrate concentration at which the reaction velocity is half of the maximal 
velocity, Vmax. The Michaelis–Menten plot is depicted in Figure 1.1. From Figure 1.1, it can be 
noted that at low [S], substrate availability limits the reaction rate, and thus the reaction velocity, 
v, increases proportionally with [S]. At much higher [S], the reaction velocity, v, reaches Vmax. At 
Vmax all enzyme molecules have substrate bound to them. Adding more substrate will not 


























                                              (1.3) 
According to Equation 1.3, a plot of 1/v versus 1/[S] yields a straight line with a slope of Km/Vmax 











Lineweaver–Burk plot. By fitting the experimental data linearly in a Lineweaver–Burk plot, the 












Enzyme assays are experimental measurements of enzyme activity. In order to generate a 
Michaelis–Menten plot and a Lineweaver–Burk plot for the determination of two important 
parameters in enzyme kinetics, Km and Vmax, enzyme assays are performed by measuring the 
velocity of an enzyme-catalyzed reaction at varying substrate concentrations. The reaction 
velocity is determined by monitoring product formation or substrate depletion as a function of 
time [2, 4, 6]. Reaction progress curves similar to those illustrated in Figure 1.3 can be observed. 





Sdv ][][ =−=                                                   (1.4) 
 

















In a typical enzyme assay, all but one of the required components for the enzyme-catalyzed 
reaction are added to the reaction vessel. This mixture of components is then equilibrated under 
certain conditions of pH, temperature, and ionic strength. Afterwards, the reaction is started by 
adding a small volume of a concentrated stock solution of the missing component, which can be 
the enzyme or the substrate, and by mixing the reaction mixture rapidly right after the addition. 
The initiating component is added as a small volume so that the experimental conditions of the 
reaction mixture do not change significantly [2, 4]. 
Detection in enzyme assays relies on a unique property of the substrate or product. 
Sometimes the substrate and product need to be separated before detection. Separation and 
detection methods that have been applied for enzyme assays include HPLC, gel electrophoresis, 
absorbance, fluorescence, radiochemical and electrochemical techniques. In direct assays, the 
substrate or product concentration can be measured directly as a function of time. When the 
substrate and product do not provide a distinct signal, indirect assays are carried out by coupling 
the enzyme-catalyzed reaction to another enzymatic or nonenzymatic reaction to produce a 
convenient signal for detection [2, 4]. 















1.2 Enzyme Assays Based on Capillary Electrophoresis (CE) 
Capillary electrophoresis (CE) has emerged as a powerful separation tool. With the 
application of an electric field, CE separates compounds based on their differential mobilities, 
which depend upon the charge, size and shape of the individual compounds as well as the 
viscosity of the electrophoresis buffer [17, 18]. Capillary electrophoresis has been successfully 
applied for the study of enzyme assays [19-25]. Compared to traditional enzyme assay methods, 
CE has several significant advantages. The amount of sample used in CE is extremely small due 
to the small dimensions of capillaries and microfabricated devices. Capillary electrophoresis is 
capable of separating the reaction products from the substrates with high efficiency. Capillary 
electrophoresis also offers high-speed analysis compared to other separation techniques. 
Furthermore, CE can be used in conjunction with several detection methods, such as UV-vis 
spectrometry, laser-induced fluorescence (LIF), mass spectrometry (MS), and electrochemical 
detection (EC). In addition, CE has excellent quantitation capabilities for studying enzyme 
assays [19-25].  
Capillary electrophoresis was initially used only as a separation tool in the determination of 
enzyme activities, and the enzyme-catalyzed reactions were performed off-line [20, 21]. In off-
line enzyme assays, all components of an enzyme-catalyzed reaction are first mixed outside the 
capillary and incubated for a period of time. Then, the reaction mixture is injected into the 
capillary for separation of the substrate and product. Although off-line CE-based enzyme assays 
offer some advantages such as highly efficient separation and high sensitivity, it has limitations. 
The enzyme-catalyzed reaction and sample analysis do not occur at the same time. Before 
injection of the reaction mixture into the capillary, the reaction must be completely stopped by 




Although the sample volume needed for CE analysis is only a few nanoliters, much larger 
volumes of reaction components are needed to carry out the reaction. In order to shorten the 
delay period between the time of reaction and the time of analysis and to reduce the consumption 
of reaction reagents, the reaction should be conducted on-line, inside the capillary [20, 21].  
On-line enzyme assays in CE can be classified into two categories: heterogeneous assays and 
homogeneous assays [20, 23, 25]. In a heterogeneous enzyme assay, either the enzyme or the 
substrate (most often the enzyme) is immobilized inside the capillary or the channel on a 
microchip to create an enzyme microreactor. The enzyme-catalyzed reaction takes place between 
the immobilized reaction component and the free solution component. The resultant product is 
directly transported to the end of the capillary and then detected. Heterogeneous enzyme assays 
have several advantages. The stability of the immobilized enzyme often is enhanced compared to 
the enzyme in free solution. Enzyme microreactors also can be reused conveniently. The enzyme 
immobilized on a solid support can be easily separated from the substrate and product. However, 
enzyme activity may be changed due to immobilization. Also, the preparation procedure of an 
enzyme microreactor can be complicated and time-consuming [20, 23, 25, 26].  
In a homogeneous enzyme assay inside the capillary or on a microchip, the enzyme-catalyzed 
reaction occurs with all reaction components including the enzyme and the substrate in the buffer 
solution [20-23, 25]. Unlike in heterogeneous assays, the enzyme in homogeneous assays 
remains in solution. Therefore, enzyme kinetic studies performed by homogeneous CE assays 
can produce results similar to those obtained with traditional assays. One problematic issue in 
homogeneous assays is that the enzyme can adsorb undesirably to the capillary wall or the 




The first on-line homogeneous enzyme assay in CE was described by Bao and Regnier in 
1992 [27]. The capillary was first filled with the substrate (S) and also the required coenzyme 
(Figure 1.4a). Then, a plug of the enzyme (E) was injected into the capillary (Figure 1.4b). As 
the enzyme migrated through the capillary by electrophoresis, it interacted with the substrate to 
form the enzyme-substrate complex (ES) and produce the product (P) (Figure 1.4c), which was 
detected at a downstream absorbance detector (Figure 1.4d). This type of assay, based on an 
enzyme-catalyzed reaction carried out electrophoretically in a capillary column, was later termed 
electrophoretically mediated microananlysis (EMMA), and this specific format was defined as 
continuous engagement EMMA [21-25]. The typical procedure for carrying out enzyme assays 
using continuous engagement EMMA is depicted in Figure 1.4. In continuous engagement 
EMMA, a product plateau is formed since the product is produced from the continuous 
interaction between the substrate and the migrating enzyme plug. In order to increase product 
formation, the applied high voltage can be turned off for incubation. With this zero-potential 









                   Figure 1.4. Continuous engagement EMMA. (a) A capillary filled with substrate. 














The second type of EMMA is transient engagement EMMA, which is also called plug-plug 
mode EMMA. In transient engagement EMMA (Figure 1.5), the enzyme (E) and the substrate (S) 
are injected into the capillary as separate plugs, with the reaction component with lower 
electrophoretic mobility injected first (Figure 1.5a). Upon the application of an electric field, 
these two plugs merge (Figure 1.5b-c) and then separate from each other (Figure 1.5d) due to 
differences in their electrophoretic mobilities. During the time period when the two plugs are 
overlapped, the enzyme-catalyzed reaction takes place and the enzyme-substrate complex (ES) is 
formed to generate product (P) in the capillary (Figure 1.5b-c). The reaction components are later 










Electrophoretically mediated microananlysis (EMMA) has been applied in many enzymatic 
systems to carry out enzyme activity assays, determine Michaelis constants (Km) for enzyme 
kinetic studies and study enzyme inhibition [21, 23, 28]. β-Galactosidase assays were performed 
on microchip by Burke and Regnier using continuous engagement EMMA with laser-induced 
fluorescence (LIF) detection [29], and in capillary by Kanie et al. using transient engagement 
Figure 1.5. Transient engagement EMMA. (a) Injection of enzyme and substrate. (b) Start of 













EMMA with UV detection [30].  Jin et al. reported the determination of zeptomole amounts of 
glucose-6-phosphate dehydrogenase in human erythrocytes and the measurement of alkaline 
phosphatase isoenzymes in individual fibroblast cells of mouse bone marrow by a combination 
of zero-potential incubation in capillary and electrochemical detection (EC) [31, 32]. 
Hoogmartens et al. described a kinetic study of phenol sulfotransferase SULT1A1 by CE-UV 
and determined its Km value [33]. The use of EMMA in enzyme inhibition studies will be 
discussed in Section 1.4.  
1.3 Enzyme Inhibition 
Enzyme inhibitors are molecules that reduce the rate of an enzyme-catalyzed reaction by 
binding to the enzyme molecule [1-7]. Enzyme inhibitors can decrease the activity of specific 
enzymes, and they are used commercially as herbicides[34, 35] and pesticides [36, 37]. Many 
diseases are caused by dysregulated enzyme activity or by infectious organisms such as viruses 
and bacteria. Enzyme inhibitors, e.g. aspirin and captopril, are used as drugs to kill a pathogen or 
to modulate metabolic pathways in patients. Enzyme inhibitors have been central to the drug 
discovery and development process [7, 38]. Moreover, a better understanding of the mechanism 
of enzyme catalysis can be gained from enzyme inhibition studies [1, 4, 7]. 
Enzyme inhibitors bind to the enzyme either reversibly or irreversibly. The bonding between 
a reversible inhibitor and the enzyme is nonconvalent, and the enzyme-inhibitor complex 
dissociates rapidly. The dissociation constant for the enzyme-inhibitor complex, Ki, is a measure 
of the affinity between the inhibitor and the enzyme.  








Ki is defined as the inhibition constant in reversible inhibition. It is commonly used to describe 
the potency of an inhibitor [1, 3-7]. 
There are three types of reversible inhibitors: competitive, noncompetitive, and 
uncompetitive inhibitors. They are classified according to how the inhibitor interactions with 
enzyme affect the equilibrium in an enzyme-catalyzed reaction. The Lineweaver–Burk plot can 
be used to illustrate the effect of the three types of reversible inhibition (Figure 1.6a-c) [1, 3-7]. 
In competitive inhibition, the inhibitor usually resembles the structure of the substrate, and it 
competes with the substrate for binding to the active site on the enzyme. The bindings of the 
inhibitor and the substrate are mutually exclusive, and the inhibitor only binds to the free enzyme 
molecule.  The maximal velocity Vmax is not affected by competitive inhibition. Both the 
Michaelis constant Km and also the slope in Lineweaver–Burk plot Km/Vmax are increased (Figure 
1.6a) [1, 3-7]. 
In noncompetitive inhibition, the inhibitor binds to a site different from the enzyme’s active 
site. The inhibitor and the substrate can bind simultaneously to an enzyme molecule. The 
substrate binds to E and EI, and the inhibitor binds to E and ES; however, the created ESI cannot 
form product. When the affinity of the inhibitor for the free enzyme and the ES complex are 
equivalent, a Lineweaver–Burk plot like the one in Figure 1.6b is generated, in which the lines 
converge at the x-axis. When the inhibitor binds with greater affinity to the free enzyme, the lines 
intersect above the x-axis; when the inhibitor has preferential affinity for the ES complex, the 
lines intersect below the x-axis. For all situations of noncompetitive inhibition, Vmax is decreased 
and Km/Vmax is increased (Figure 1.6b) [3-7]. 
In uncompetitive inhibition, the inhibitor also binds to a site on the enzyme other than the 




The resulting ESI is a dead end complex, and cannot form product. Both Km and Vmax are 
decreased equally in the presence of an uncompetitive inhibitor, and thus the slope Km/Vmax is 










































Unlike reversible inhibitors that dissociate from the enzyme, an irreversible inhibitor forms 
covalent bond with the enzyme molecule and does not dissociate. The enzyme is permanently 
inactivated due to the irreversible interaction between the inhibitor and enzyme. Therefore, 
irreversible inhibitors are also known as enzyme inactivators. Since the formation of covalent 
bonds is relatively slow, irreversible inhibitors display time dependency. The degree of inhibition 
increases with time after the irreversible inhibitor interacts with the enzyme [3-7]. 
1.4 On-line Enzyme Inhibition Assays Based on CE 
On-line enzyme assays in CE have been employed to study enzyme inhibition [28]. 
Heterogeneous enzyme inhibition assays based on CE have been reported in which enzymes are 
immobilized onto a capillary or a microfabricated device [39-41]. Tang and Kang described 
inhibition assays of angiotensin-converting enzyme (ACE) in an on-column microreator, which 
was created by an ionic binding technique [40]. The capillary was first coated with 
hexadimethrine bromide (HDB). A short plug of enzyme was then incubated with the positively 
charged HDB and was immobilized on inlet part of the capillary wall via ionic bonding. After 
flushing the capillary with the running buffer, enzyme inhibition assays were carried out by 
hydrodymanically injecting a mixture of the inhibitor and the substrate hippuryl-His-Leu (HHL). 
After incubation of the substrate with the immobilized enzyme, an electric field was applied to 
separate the substrate HHL and the product hippuric acid (HA), which were then detected by UV 
absorbance. Captopril and cilazaprilat were investigated in the inhibition assays, and were 
confirmed as competitive and noncompetitive ACE inhibitors, respectively.  
Enzyme assays based on continuous engagement EMMA have also been applied to study 
enzyme inhibition [42, 43]. Using continuous engagement EMMA, Belenky and coworkers 




the substrate solution, and this mixture was used to fill the capillary. After the enzyme was 
injected and migrated for some time in the capillary, the voltage was turned off for zero-potential 
incubation. Inhibition assays were performed using this method to screen inhibitors of protein 
tyrosine phosphatase in a natural extract. Hadd et al. used continuous engagement EMMA to 
study the inhibition of β-galactosidase on a microchip device [43]. The substrate, buffer, enzyme, 
and inhibitor were held in separate reservoirs and mixed electrophoretically. The substrate and 
the buffer were first mixed in the upstream channel. The enzyme and the inhibitor were then 
added to the diluted substrate solution at a cross intersection to carry out the enzyme-catalyzed 
reaction in the downstream channel. The generated product was fluorescent and was detected by 
a downstream laser-induced fluorescence (LIF) detector. The inhibition of β-galactosidase by 
three inhibitors, phenylethyl β-D-thiogalactoside (PETG), p-hydroxymercuribenzoic acid 
(PHMB) and D-lactose was investigated. 
In addition, enzyme inhibition assays using transient engagement EMMA have been reported 
[44-48]. The inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine 
(EHNA) was studied by Saevels et al. using the traditional mode of transient engagement 
EMMA as illustrated in Figure 1.5 [44]. The inhibitor, EHNA, was added to the running buffer, 
the enzyme solution and also the substrate solution to carry out the enzyme inhibition assays. 
The Glatz research group employed the partial filling technique, a modification of transient 
engagement EMMA, to perform inhibition studies of rhodanese and haloalkane dehalogenase 
[45-47]. The partial filling technique was first introduced by Van Dyck et al., and offers the 
advantage of using different buffer systems for carrying out the enzyme-catalyzed reaction and 
separating the reaction components [49]. Using the partial filling technique, the Glatz research 




alanine buffer at pH 3.5 for CE separation. The enzyme and a mixture of the substrate and 
inhibitor were prepared in HEPES buffer at pH 8.5, which is optimal for the enzyme-catalyzed 
reaction, and were then injected into the capillary subsequently as distinct zones. In order to 
shield the reaction component plugs from the separation buffer and to provide a suitable 
environment for the reaction to take place, a plug of HEPES buffer at pH 8.5 was injected before 
the enzyme zone and also after the substrate and inhibitor zone. The Ki values of 2-oxoglutarate 
with respect to each substrate, thiosulfate and cyanide, were determined. This laboratory later 
used the same technique to investigate the inhibition of haloalkane dehalogenase by a 
competitive inhibitor 1,2-dichloroethane and the substrate inhibition of this enzyme by 1,2-
dibromoethane [46, 47]. 
Whisnant et al. in our lab used a combination of continuous engagement EMMA and 
transient engagement EMMA to study the inhibition of alkaline phosphatase [50, 51]. The 
capillary was first filled with a solution of the fluorogenic substrate, AttoPhos (2'-[2-
benzothiazoyl]-6'-hydroxybenzothiazole phosphate), which would be converted to a fluorescent 
product by the catalysis of alkaline phosphatase. Then, the inhibitor and enzyme were injected 
electrokinetically into the capillary as separate plugs, with the inhibitor being injected first since 
it has a lower electrophoretic mobility compared with the enzyme-substrate complex. After this, 
a constant high voltage was applied to carry out the inhibition assay. As the enzyme-substrate 
complex migrated through the capillary under the electric field, the fluorescent product was 
generated continuously, which was observed as a plateau by a downstream laser-induced 
fluorescence (LIF) detector (Figure 1.7). Moreover, the zones of inhibitor and enzyme-substrate 
complex mixed electrophoretically as the faster moving enzyme-substrate complex zone 




reaction slowed down due to the inhibition, resulting in formation of less product. For a 
reversible inhibitor, the enzyme activity was restored after the zones of inhibitor and enzyme-
substrate complex were separated from each other. A negative inhibition peak was observed on 
the product plateau as shown in Figure 1.7. The inhibition types and Ki values of three reversible 
inhibitors, theophylline, sodium vanadate and sodium arsenate, were determined. In addition, the 
authors also demonstrated the use of this method to investigate the irreversible inhibition of 










Compared to traditional enzyme assays in microplates, this CE-based technique requires 
significantly less enzyme. Using this on-line EMMA method, reversible inhibition and 
irreversible inhibition can be easily distinguished based on the shape of electropherograms. It is 
capable of quantifying competitive and noncompetitive reversible inhibitors using Michaelis–
Menten treatment of the data and determining Ki values for these inhibitors.  
This CE-based enzyme inhibition assay is not suitable for the separation of mixtures of 
enzyme inhibitors since it has a very low peak capacity. The peak capacity (nc) is the maximum 
Figure 1.7. Electropherogram of a theophylline-alkaline phosphatase 




number of separated peaks that can fit into the path length or space provided by the separation 
method with adjacent peaks at a specified resolution (Rs) value [17]. The peak capacity is a 
figure of merit for quantifying the ability of a separation method to resolve complex mixtures, 




                                                           (1.6) 
where L is the total path length or space of separation, and w is the peak width. In the enzyme 
inhibition assays developed by Whisnant et al. [50, 51], the space for separation of mixtures of 
enzyme inhibitors is the width of the plateau, and the peak width is the width of the negative 
inhibition peak at the baseline. As can be seen in Figure 1.7, L is about 21 s, and w is about 6 s. 
Therefore, nc is about 3, which means that at most three inhibitors can be separated by using this 
method. This value of the peak capacity is not high enough for the purpose of separating a 
mixture of enzyme inhibitors.  
This thesis presents the development of a new approach for enhancing the peak capacity for 
enzyme inhibitor separations using on-line enzyme inhibition assays based on CE. To perform 
the enzyme assays and separate enzyme inhibitors, an on-column enzyme microreactor was 
constructed by coating the magnetic beads with alkaline phosphatase and holding the magnetic 
beads in place by a magnet at the downstream part of the capillary. Enzyme inhibitors were 
separated in capillary before they reached the immobilized enzyme. Individual inhibitors moved 
downstream, passed the enzyme zone, and were detected as negative peaks. Using this approach, 
separations of five inhibitors of alkaline phosphatase (theophylline, sodium orthovanadate, 






CHAPTER 2  
CAPILLARY ELETROPHORETIC SEPARATIONS OF ENZYME INHIBITORS WITH 
ACTIVITY-BASED DETECTION 
2.1 Introduction 
Because enzyme catalysis plays a central role in biological chemistry, enzymes are one of the 
most important classes of drug targets, and enzyme inhibitors have been central to the drug 
discovery and development process [7]. Rapid, inexpensive and information-rich analytical 
techniques are needed for enzyme inhibitor screening [7]. When potential enzyme inhibitors are 
part of a synthetic or natural mixture of compounds, it would be desirable to use analysis 
methods that simultaneously separate compounds in the mixture and examine their inhibition of 
a target enzyme.  
Capillary electrophoresis (CE) has been successfully applied for studies of enzyme kinetics 
and enzyme inhibition in both capillaries and microchips [23, 28]. Whisnant et al. developed a 
method combining continuous engagement EMMA and transient engagement EMMA to study 
the inhibition of alkaline phosphatase in a capillary [50, 51]. In principle, this EMMA method 
could be used to perform inhibitor separations together with enzyme inhibition assays; however, 
poor peak capacity limits this approach in practice. For example, the peak capacity based on 
studies of the reversible inhibition of alkaline phosphatase by theophylline is calculated to be 3 
[51]. In 1999, Hadd et al. reported an EMMA-based method in a microchip device, which could 
separate mixtures of inhibitors and detect them based on their inhibition of the target enzyme 
[52]. Four inhibitors of acetylcholinesterase, tetramethylammonium chloride, 
tetraethylammonium chloride, tacrine and edrophonium, were separated and detected as negative 
peaks due to reduced product formation. Despite the promise of this early study, no subsequent 




Described here is a simple, on-column CE method in a capillary for separating mixtures of 
inhibitors and detecting these molecules based on their inhibition of a target enzyme. To 
overcome the limited peak capacity of the EMMA method developed by Whisnant and 
coworkers [50, 51], the enzyme was immobilized in the CE capillary before the detector by 
immobilizing enzyme-coated paramagnetic beads with a magnetic field [53]. The enzyme 
inhibitors were separated by CE before reaching the enzyme microreactor. The effects of several 
experimental variables on the assays, such as bead injection time and separation potential, were 
investigated. Five reversible inhibitors of alkaline phosphatase were separated, and their 
individual inhibition peaks were observed using this approach. This method was directly 
compared to the EMMA method reported by Whisnant et al. [50, 51] using the same enzyme and 
mixture of inhibitors. 
2.2 Materials and Methods 
2.2.1 Reagents  
Alkaline phosphatase (EC 3.1.3.1 from calf intestine) and AttoPhos (2´-[2-benzothiazoyl]-6´-
hydroxybenzothiazole phosphate) were obtained from Promega (Madison, WI). Sodium 
phosphate and sodium hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ). 
Sodium vanadate was from Acros Organics (Pittsburgh, PA). Other chemicals were supplied by 
Sigma-Aldrich (St. Louis, MO). All solutions were prepared in ultrapure water (> 18 MΩ·cm) 
from a Modulab water purification system (United States Filter Corp.; Palm Desert, CA). 
2.2.2 CE-LIF Instrumentation  
The CE-LIF instrument was constructed in house and is similar to previous instruments [50, 
51]. Figure 2.1 shows a schematic representation of the instrument. The LIF detector is not 




Carlsbad, CA) was used for excitation. The laser beam was focused onto the capillary by a CaF2 
plano convex lens (f = 20.0 mm) (Thorlabs; Newton, NJ). The laser power at the capillary was 
24.0 mW. The fluorescence was collected at 90° relative to the excitation beam by a 20× 
microscope objective (0.5 NA; Melles Griot; Carlsbad, CA), and was filtered by a 560 ± 10 nm 
bandpass filter (53900, Oriel; Stratford, CT) and an 800 µm diameter pinhole (Oriel). The 
fluorescence was then detected by a PMT (HC120-01, Hamamatsu; Bridgewater, NJ) at a 
potential of 1000 V. The PMT output was filtered by a low-pass filter at 50 Hz, and the data 
were collected at 20 Hz by the data acquisition board (PCI-6229, National Instruments; Austin, 
TX). A LabVIEW program (Version 7.1, National Instruments) was written and used for data 










A Spellman CZE1000R high-voltage power supply (Hauppauge, NY) was used to apply the 
electrophoretic potential. Fused silica capillaries with a 50 µm i.d. and 220 µm o.d. from SGE 
(Austin, TX) were used. For all experiments, the capillaries were 60.0 cm total length and 45.0 













Figure 2.1. Diagram of the CE-LIF instrument. The copper block was used to hold the 
magnet (M) in place and to thermostat the capillary in the region where the enzyme-coated 




coating using a window maker (MicroSolv Technology; Eatontown, NJ). Each new capillary was 
rinsed before use with 0.1 M NaOH, water, and then diethanolamine (DEA) buffer (50.00 mM, 
pH 9.50) using a manual syringe pump for 10 min, respectively. All solutions used for CE were 
filtered through a 0.2-µm membrane filter (Whatman; Hillsboro, OR). 
2.2.3 Enzyme Immobilization on Magnetic Beads 
Superparamagnetic polystyrene beads (Dynabeads M-270 Epoxy) with diameters of 2.8 µm 
were purchased from Invitrogen Dynal (Olso, Norway). The covalent attachment of alkaline 
phosphatase to the magnetic beads was performed using the protocol provided by the 
manufacturer. Briefly, a batch of magnetic beads (1.5 mg, 1.0×108 beads) was washed twice with 
100 µL of 100.0 mM sodium phosphate buffer at pH 7.40. In each washing step, the beads were 
separated from the wash buffer by immobilizing the bead suspension with a NdFeB magnet and 
removing the supernatant. The washed beads were then resuspended in 30 µL of the sodium 
phosphate buffer (3.3 × 109 beads/mL). After mixing the 30-µL suspension of washed beads and 
30 µL of 14 µM alkaline phosphatase in the same phosphate buffer, 30 µL of 3.000 M 
ammonium sulfate in the pH 7.40 phosphate buffer was added to enhance binding of alkaline 
phosphatase to the beads. The resultant mixture was incubated with slow tilt rotation on a 
rocking platform for 24 h at room temperature. After incubation, the beads were washed four 
times with 150 µL aliquots of DEA buffer (50.00 mM, pH 9.50) to remove alkaline phosphatase 
molecules that were not covalently attached to the beads. Finally, the beads were resuspended in 
200 µL DEA buffer (5.0 × 108 beads/mL) and stored in the refrigerator at 4 °C until use. The 
coated bead suspensions were diluted to a concentration of 1.7 × 108 beads/mL, and the 





2.2.4 Magnetic Bead Immobilization in the Capillary 
A copper holder was constructed to hold the magnets that immobilized the magnetic beads 
inside the capillary and to control the temperature in this region of the capillary. This holder is 
illustrated in Figure 2.1. The holder positioned the magnet(s) near the capillary surface, 27.0 cm 
from injection end of the capillary. Water from a thermostatted bath was circulated through the 
copper holder to control the temperature of a 5.0-cm section of the capillary, centered at the 
magnet. Permanent NdFeB magnets (B442 and D24) used in this work were purchased from 
K&J Magnetics (Jamison, PA). A B442 magnet (3700 Gauss) was secured in the holder with one 
pole perpendicular to the capillary bore. The distance from the center of the capillary bore to the 
face of the magnet closest to the capillary was 350 µm. In a 2-magnet configuration, a pair of 
D24 magnets (3895 Gauss) was secured in the holder. The two magnets were arranged at ±20° 
relative to the longitudinal axis of the capillary bore with their north poles facing the capillary 
bore [54]. The distance from the inner edge of each magnet to the center of the capillary bore 
was 395 µm. To create an enzyme microreactor with magnetic beads, the beads coated with 
alkaline phosphatase were electrokinetically injected into the capillary at 300 V/cm and then 
transported to the immobilization zone by electrophoresis (200 V/cm) in DEA buffer (50.00 mM, 
pH 9.50). After experiments, the beads could be easily removed by rinsing the capillary with 
DEA buffer using a manual syringe pump. 
An inverted microscope (Nikon ECLIPSE TE 300) was used with a 10× objective to image 
immobilized magnetic beads inside the capillary. Images for the 1-magnet configuration were 
captured by a CCD camera and an imaging software (WinView Software Version 32) from 
Princeton Instruments (Trenton, NJ). A digital camera (Sony DSC-W55/P; Sony Electronics, Inc.) 




eyepiece diopter of the microscope. The bead plug lengths were measured using the inner 
diameter of the capillary (50 µm) as a reference. 
2.2.5 Enzyme Assays 
For heterogeneous enzyme assays in a capillary with immobilized magnetic beads, the 
running buffer was 0.100 mM AttoPhos in 50.00 mM DEA at pH 9.50. AttoPhos is a fluorogenic 
substrate for alkaline phosphatase. All inhibitor solutions were prepared in the running buffer. 
Inhibitors were electrokinetically injected at 200 V/cm for 3.0 s. The applied electric field for 
carrying out the enzyme assays was 200 V/cm unless otherwise noted. The electrode and the 
capillary inlet were dipped in DEA buffer before and after each injection of inhibitor to prevent 
cross contamination of the running buffer and inhibitor solution. The capillary was thermostatted 
at 25.0 °C. To analyze the data for heterogeneous enzyme inhibition assays, peak capacity (nc) 





                                                         (2.1)
 
where t is the migration time of an inhibitor, and w1/2 is the full width at half maximum of an 
inhibition peak [17]. 
For homogeneous CE enzyme inhibition assays, the basic experimental procedures were the 
same as those described previously [51]. The capillary was filled with the same running buffer 
used for the heterogeneous enzyme inhibition assay, including substrate. A zone of an alkaline 
phosphatase inhibitor, theophylline, was first injected for 3.0 s at 12.0 kV into the capillary. A 
potential of 12.0 kV was then applied for 30.0 s (40.0 s when a mixture of inhibitors was 
injected). Next, a plug of 51 pM alkaline phosphatase was injected for 3.0 s at 12.0 kV. Finally, a 
separation potential of 12.0 kV (200 V/cm) was applied. The enzyme concentration for 




in DEA buffer or the enzyme immobilized on magnetic beads and then comparing their product 
fluorescence signals. The inhibitor solutions contained the inhibitor as well as 0.100 mM 
AttoPhos in 50.00 mM DEA at pH 9.50. The electrode and the capillary inlet were dipped in 
DEA buffer before and after each injection to prevent cross contamination of the running buffer, 
enzyme solution and inhibitor solution. The thermostatting system for the homogeneous assays 
was constructed as described previously [51]. To thermostat the capillary, Teflon tubing was 
used to enclose the capillary from the injection end to the detection window, and N2 (25.0 °C, 8 
psi) flowed through the Teflon tubing around the capillary. The temperature of the N2 was 
controlled by passing it through a coil of tubing in a temperature-controlled water bath before it 
passed over the capillary to control the capillary temperature. 
2.3 Results and Discussion 
2.3.1 Enzyme Microreactors for Enzyme Inhibition Assays  
The goal for this work was to expand the ability of our CE enzyme inhibition assays to 
separate and detect mixtures of inhibitors [50, 51]. The approach presented here is to immobilize 
the enzyme of interest inside the capillary before the detector. The running buffer contains a 
fluorogenic substrate for the target enzyme – AttoPhos and alkaline phosphatase in this work. 
Inhibitor mixtures will separate by CE before reaching the enzyme microreactor, and they will 
produce a negative inhibition peak (reduced fluorescent product formation) as they migrate 
through the enzyme microreactor and inhibit the enzyme. Chetwyn and Susan Lunte used a 
related approach to separate and detect mixtures of acetylcholinesterase inhibitors based on an 
enzyme-modified electrode placed at the end of a CE capillary [55]. In the work presented here, 




The enzyme microreactors were constructed using rare earth magnets to immobilize enzyme-
coated magnetic beads inside the capillary before the detection window [53]. Two different 
magnet configurations were used in this work. In both configurations, the magnets were placed 
27.0 cm from injection end of the capillary. In the one-magnet configuration, a single B442 
magnet (3700 Gauss) was placed with the face of the square magnet 350 µm from the center of 
the capillary bore with its pole facing the capillary bore. In the two-magnet configuration, two 
D24 magnets (3895 Gauss) were positioned at ±20° relative to the long axis of the capillary with 
their north poles facing the capillary [54]. The distance from the center of the capillary bore to 
the inner edge of each magnet was 395 µm. In both configurations, the magnets were able to 



























Figure 2.2. Electropherogram showing fluorescence without and with alkaline 
phosphatase substrate, Attophos, in the running buffer with an enzyme microreactor. 
A single B442 magnet (3700 Gauss) was used to immobilize magnetic beads inside 
capillary. Magnetic beads (1.7 × 108 beads/mL) coated with alkaline phosphatase in DEA 
buffer (50.00 mM, pH 9.50) were injected for 30.0 s at 18.0 kV (300 V/cm). Next, a 
potential of 12.0 kV (200 V/cm) was applied to the capillary filled with DEA buffer to 
transport the beads to the immobilizing magnet. Then the capillary was filled 
electrokinetically with substrate buffer containing 0.100 mM AttoPhos (50.00 mM DEA, 




The use of magnetic immobilization of enzyme-labeled beads greatly simplified the 
development and optimization of this approach to CE-based enzyme inhibition assays. Enzyme 
microreactors could be constructed simply by electrokinetically injecting enzyme-coated 
magnetic beads into a capillary and then transporting the beads to the immobilizing magnet by 
electrophoresis in DEA buffer. No modification of the inner capillary surface was required. 
Figure 2.2 shows the increase in fluorescence when the DEA buffer used for immobilization 
(without substrate) is replaced with DEA buffer containing the substrate, AttoPhos.  
2.3.2 Optimization of the Enzyme Assay 
The temperature at the enzyme microreactor and the concentration of substrate in the running 
buffer were optimized before beginning enzyme inhibition studies. A 5.0 cm section of the 
capillary centered at the magnet was temperature controlled by circulating water from a 
thermostatted bath through the copper holder. The optimum temperature (maximum enzyme 
activity) was found to be 25 °C using the one-magnet configuration for immobilizing the alkaline 
phosphatase-coated magnetic beads. The data are presented in Figure 2.3. Although the 
temperature of the capillary was controlled externally at 25 °C, it is important to note that the 
temperature in the bore of the capillary will be higher than this due to Joule heating [56]. The 
electrophoretic current for this experiment was 3.9 µA. 
The substrate concentration was optimized by measuring the fluorescence signal when 
buffers with AttoPhos concentrations ranging from 0.005 to 0.500 mM were allowed to 
electrophorese through the capillary at 200 V/cm. The fluorescence signal due to product 
formation at each AttoPhos concentration was recorded when it became stable. Figure 2.4 shows 




the experimental data nonlinearly to the Michaelis–Menten equation. An AttoPhos concentration 






































Figure 2.4. Plot of product fluorescence vs. substrate concentration. Experimental 
conditions are the same as in Figure 2.2. 
Figure 2.3. Fluorescence vs. external temperature at the enzyme microreactor for 
CE assays of alkaline phosphatase. Experimental conditions are the same as in 
Figure 2.2. 




















2.3.3 Inhibition Assays 
An electropherogram of an enzyme inhibition assay for sodium arsenate, a reversible 
competitive inhibitor of alkaline phosphatase, is presented in Figure 2.5. The enzyme 
microreactor was constructed using a single magnet. The enzyme microreactor first was filled 
with a 0.100 mM AttoPhos solution to obtain a constant fluorescence signal from the enzyme-
catalyzed reaction product. Then, 0.125 mM sodium arsenate was injected for 3.0 s at 12.0 kV. 
Finally, a separation potential of 12.0 kV was applied. At 11.2 min, a decrease in product 
formation was observed due to the inhibitor zone passing through the plug of enzyme-coated 
magnetic particles. After the inhibitor zone migrated past the plug of beads, the product 
fluorescence returned to its original level and the enzyme activity was restored, demonstrating 




























Figure 2.5. Electropherogram of an enzyme inhibition assay (inhibition of alkaline 
phosphatase by arsenate) using an enzyme microreactor constructed with a single 
magnet. Experimental conditions for loading the magnetic beads are the same as in Figure 2.2, 
and the same running buffer and substrate concentration were used. The inhibitor, 0.125 mM 





The electropherogram also contains several artifact peaks. The unresolved peaks at ~2.3 min 
result from product formation during zero-potential incubation. The first peak was generated 
after the high voltage was turned off just before the inhibitor was injected into the capillary, and 
the second peak was generated after the inhibitor injection and before the application of the 
separation potential. There are also two reproducible artifact peaks (a positive peak and a 
negative peak) at ~4.9 min, and the cause of these two peaks is unclear. Electropherograms for 
the same experiments carried out in an enzyme microreactor constructed with two magnets 












The inhibition of alkaline phosphatase by theophylline was also studied with both enzyme 
microreactors. Theophylline is a reversible, noncompetitive inhibitor of alkaline phosphatase. An 
electropherogram for a 3.0-s injection of 1.00 mM theophylline is shown in Figure 2.7. The 
Figure 2.6. Electropherogram of an enzyme inhibition assay (inhibition of alkaline 
phosphatase by arsenate) using an enzyme microreactor constructed with two magnets. 
Experimental conditions are the same as in Figure 2.5. 


















negative peak at 8.4 min is due to theophylline inhibition. The artifact peaks are almost identical 













2.3.4 Effects of Electric Field Strength and Bead Injection Time on Peak Capacity 
The effects of the electric field strength and bead injection time on the peak capacity (nc) for 
separation of reversible inhibitors were investigated to optimize the ability of the enzyme 
inhibition assays to resolve mixtures of inhibitors. Inhibition assays of alkaline phosphatase by 
arsenate were performed at different electric field strengths using enzyme microreactors 
constructed with one and two magnets. A plot of the peak capacity vs. field strength is presented 
in Figure 2.8. For both types of enzyme microreactors, the peak capacity decreases with 
increased electric field strength. Taking into consideration both the peak capacity and the total 
analysis time, an electric field strength of 200 V/cm was chosen for later experiments (nc ≈ 20).  















Figure 2.7. Electropherogram of an enzyme inhibition assay (inhibition of alkaline 
phosphatase by theophylline) using an enzyme microreactor constructed with a single 
magnet. The inhibitor, 1.00 mM theophylline, was injected for 3.0 s at 12.0 kV, and then the 
separation potential of 12.0 kV was applied. Magnetic beads (1.7 × 108 beads/mL) were 















The results of inhibition assays (arsenate, alkaline phosphatase) with different bead injection 
times using both microreactor configurations are presented in Figure 2.9. Increasing the bead 
injection time increases the total number of beads injected and the bead plug length (Figure 2.10). 
The image of a bead plug at bead injection time of 15 s for the 2-magnet configuration is shown 
in Figure 2.10. The density of magnetic beads in a plug is difficult to be determined from 2-D 
images of the 3-D system.  
Figure 2.9a shows a plot of peak capacity as the bead injection time is increased from 3.0 s to 
90 s. For both magnet configurations, the peak capacity decreases dramatically when the bead 
injection time is increased from 15 to 30 s. There appears to be a slight increasing trend in peak 
capacity as the injection time is increased from 30 to 90 s. The peak capacity is proportional to 
the ratio of the migration time (t) over the peak width (w1/2). For inhibition assays by arsenate, 
the migration time of the inhibitor does not change much at different bead injection times. The 
Figure 2.8. Effect of electric field strength on peak capacity (nc) for assays of alkaline 
phosphatase inhibition by arsenate. Experimental conditions are the same as in Figure 2.5, 
except that the electric field strength was varied as indicated. The electric field strength for 
each arsenate injections matched the separation field strength for that experiment. 














trend of peak capacity vs. bead injection time results mainly from the variation of the inhibition 
peak width. The inhibition peak width for inhibition assays using enzyme microreactors with 
magnetic beads is a complicated and interesting issue, and the cause of the inhibition peak 
broadening is not yet clearly and completely understood. In this study, our focus is put on 


















 Figure 2.9. Effect of bead injection time on (a) peak capacity (nc) and (b) inhibition peak S/N for assays of alkaline phosphatase inhibition by arsenate. Experimental conditions are 
the same as in Figure 2.5, except that bead injection time was varied as indicated. 
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The increase in bead injection time also affects the S/N for the inhibition peaks for both 
enzyme microreactor types as shown in Figure 2.9b. The fluorescence signal due to enzyme-
catalyzed product formation increases as the number of beads immobilized increases due to 
increased bead injection time. With longer magnetic bead injection time, the inhibition peak 
height increases; however, the baseline noise also increases. The S/N of the inhibition peak only 
changes slightly for the bead injection times investigated here. A magnetic bead injection time of 














Inhibition of alkaline phosphatase by theophylline with different magnetic bead injection 
times also was studied for both magnet configurations. These results are shown in Figure 2.11. 
The peak capacity for theophylline is less impacted by the bead injection time compared to 





















Bead injection time (s)
15 s, 2-magnet 
Figure 2.10. Effect of bead injection time on bead plug length. Magnetic beads (1.7 × 108 
beads/mL) coated with alkaline phosphatase in DEA buffer (50.00 mM, pH 9.50) were injected 
at 300 V/cm for different time periods. Then, the beads were transported to the immobilizing 





arsenate, ranging only from 17-25 for all bead injection times and both enzyme microreactor 
configurations. The S/N increases for theophylline by approximately a factor of two for both 
magnet configurations when the bead injection time is increased from 3.0 to 15 s. At longer bead 




















Figure 2.11. Effect of bead injection time on (a) peak capacity (nc) and (b) inhibition peak 
S/N for assays of alkaline phosphatase inhibition by theophylline. Experimental conditions 
are the same as in Figure 2.7, except that bead injection time was varied as indicated. 
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2.3.5 Inhibition Peak Shape and Inhibitor Concentration 
To investigate the effect of inhibitor concentration on inhibition peak shape, different 
concentrations of sodium arsenate were injected for 3.0 s using both 1 and 2-magnet enzyme 
microreactors. Figure 2.12 shows electropherograms for inhibition assays at different arsenate 
concentrations using a 1-magnet enzyme microreactor. The electropherograms are artificially 
offset vertically to more clearly show the inhibition peaks, but the fluorescence baselines were 
the same in the original electropherograms. The artifact peaks at ~5.0 min are about the same for 
assays at lower arsenate concentrations, and get deeper and wider at arsenate concentration of 
12.5 mM. The positive peaks at ~8.9 min are for fluorescein, which was used as a control since it 
is not expected to interact with the immobilized enzyme and magnetic beads. The inhibition 
peaks become deeper and broader as the inhibitor concentration increases. Plots of the inhibition 
peak width at half maximum (w1/2) vs. the inhibitor concentration (Figure 2.13) for both enzyme 
microreactor types show that the peak widths increase by more than a factor of 20 in both cases. 
The fluorescein peaks have similar peak width for both magnet configurations. The fluorescein 
peak widths are ~ 0.04 min at inhibitor concentrations from 0.0125 mM to 1.25 mM, and 
decrease to 0.01 min due to sample stacking effect at inhibitor concentration of 12.5 mM. It is 
proved by the narrowness of fluorescein peaks that fluorescein does not interact with the enzyme 
coated on magnetic beads. Furthermore, the large widths of inhibition peaks should result from 
the interaction between inhibitor and enzyme when the inhibitor migrates passing the bead plug.  
The effect of inhibitor concentration on inhibition peak shape was also studied for 
theophylline using both enzyme microreactors. The electropherograms for these experiments 
with a 1-magnet microreactor are presented in Figure 2.14. Theophylline inhibition was also 



























Figure 2.13. Plots of inhibition peak width at half maximum (w1/2) vs. inhibitor 
concentration for assays of alkaline phosphatase inhibition by arsenate. Experimental 
conditions are the same as in Figure 2.12. 

















Figure 2.12. Electropherogram of enzyme inhibition assays at different arsenate 
concentrations using an enzyme microreactor constructed with a single magnet. 
Magnetic beads (1.7 × 108 beads/mL) were injected for 15.0 s at 18.0 kV. A mixture of 0.5 
µM fluorescein and the inhibitor, arsenate, was injected for 3.0 s at 12.0 kV, and then the 
separation potential of 12.0 kV was applied. All other experimental conditions are the same 
as in Figure 2.5. The electropherograms were artificially offset along the vertical axis so the 
inhibition peaks could be viewed without overlap. 






















 electropherograms for the EMMA studies are presented in Figure 2.15. Figure 2.16 shows plots 
of the inhibition peak widths at half maximum (w1/2) vs. theophylline concentration for all three 
assays. For all three assays the peak width increases by a factor of 6 as the theophylline 
concentration increases from 0.500 to 10.0 mM. At all inhibitor concentrations, the inhibition 
peak width for heterogeneous assays is 40-110% larger than that for the homogeneous assay. For 
both heterogeneous assays and homogeneous assays, the inhibition peak width is not the physical 
length of the inhibitor plug. For heterogeneous assays, a major contribution to the inhibition peak 
width comes from the interaction between the inhibitor and the enzyme on magnetic beads. For 
homogeneous assays, the electrophoretic mobilities of the enzyme and inhibitor plugs and also 














Figure 2.14. Electropherogram of enzyme inhibition assays using an enzyme 
microreactor constructed with a single magnet at different theophylline concentrations. 
Magnetic beads (1.7 × 108 beads/mL) were injected for 15.0 s at 18.0 kV. A mixture of 0.5 
µM fluorescein and the inhibitor, theophylline, was injected for 3.0 s at 12.0 kV, and then the 
separation potential of 12.0 kV was applied. All other experimental conditions are the same as 
in Figure 2.7. The electropherograms were artificially offset along the vertical axis so the 
inhibition peaks could be viewed without overlap. 













































Figure 2.15. Electropherograms of enzyme inhibition assays using homogeneous EMMA 
at different theophylline concentrations. (a) 0.500 mM; (b) 1.00 mM; (c) 5.00 mM; (d) 
10.0 mM. A plug of the inhibitor, theophylline, was injected for 3.0 s at 12.0 kV into a 
capillary filled with 0.100 mM AttoPhos (50.00 mM DEA, pH 9.50). Next, a potential of 12.0 
kV was applied for 30.0 s. Then, a plug of 51 pM alkaline phosphatase was injected into the 
capillary for 3.0 s at 12.0 kV. Finally, a separation potential of 12.0 kV (200 V/cm) was 











































































2.3.6 Separation and Detection of Enzyme Inhibitor Mixtures 
Figure 2.17 presents a separation of a mixture of 5 inhibitors of alkaline phosphatase using a 
1-magnet enzyme microreactor. The inhibitors were electrophoretically separated in the capillary 
before reaching the enzyme microreactor, and the inhibitor zones produced negative peaks due to 
reduced product formation as they passed through the enzyme microreactor. All 5 analytes, 
tryptophan, theophylline, vanadate, arsenate and tungstate, are reversible inhibitors of alkaline 
phosphatase [57-60]. The same experiment was performed with a 2-magnet enzyme microreactor 
(Figure 2.18). All 5 inhibitors as well as fluorescein (peak 6) were resolved from each other and 
from artifact peaks in both experiments. Inhibition assays of the five species also were carried 
out individually so that the inhibition peaks could be identified according to their migration times 
(data not shown). 
Figure 2.16. Plots of inhibition peak width at half maximum (w1/2) vs. inhibitor 
concentration for assays of alkaline phosphatae inhibition by theophylline. 
Experimental conditions for heterogeneous assays using enzyme microreactors are the same 
as in Figure 2.14. Experimental conditions for homogeneous assays based on EMMA are the 
same as in Figure 2.15. 





























































Figure 2.17. Separation of alkaline phosphatase inhibitors using a 1-magnet enzyme 
microreactor. Peak identities are: 1. tryptophan; 2. theophylline; 3. sodium vanadate; 4. 
sodium arsenate; 5. sodium tungstate; 6. fluorescein. Magnetic beads (1.7 × 108 beads/mL) 
were injected for 15.0 s at 18.0 kV (300 V/cm). A mixture of five inhibitors was injected for 
3.0 s at 12.0 kV (200 V/cm). Other experimental conditions are the same as in Figure 2.5. 
Figure 2.18. Separation of alkaline phosphatase inhibitors using a 2-magnet enzyme 
microreactor. Peak identities are: 1. tryptophan; 2. theophylline; 3. sodium vanadate; 4. 
sodium arsenate; 5. sodium tungstate; 6. fluorescein. Experimental conditions are the same as 
in Figure 2.17.  






















The same separation was attempted using the homogeneous method combining continuous 
EMMA and transient engagement EMMA [50, 51]. The result of this experiment is presented in 
Figure 2.19. Only two peaks are apparent in the product plateau in the electropherogram from 6.2 
to 7.0 min. Based on the migration order of the inhibitors from the experiments in Figures 2.17 
and 2.18 as well as experiments using the homogeneous EMMA method in which the samples 
were spiked with arsenate or tryptophan, these peaks were identified as theophylline (6.5 min) 
and vanadate (6.8 min). The product plateau was so narrow that the inhibition peaks for 
tryptophan, arsenate and tungstate were not observed. Tryptophan migrated fastest among the 
five inhibitors, and its migration time should be less than 6.2 min. Arsenate had a lower 
electrophoretic mobility than vanadate. Tungstate moved slowest. Arsenate and tungstate peaks 
should be on the right edge of the product plateau. These results show that the homogeneous 
EMMA method has very limited peak capacity, and in this case it cannot separate and detect all 



























Figure 2.19. Separation of alkaline phosphatase inhibitors using homogeneous EMMA. Peak 
identities are: 1. theophylline; 2. sodium vanadate. A mixture of five alkaline phosphatase 
inhibitors was injected for 3.0 s at 12.0 kV into a capillary filled with 0.100 mM AttoPhos (50.00 
mM DEA, pH 9.50). Next, a potential of 12.0 kV was applied for 40.0 s. Then, a plug of 51.0 pM 
alkaline phosphatase was injected into the capillary for 3.0 s at 12.0 kV. Finally, a separation 





CONCLUSIONS AND FUTURE DIRECTIONS  
3.1 Conclusions 
An on-column enzyme microreactor was created for electrophoretic separations and detection 
of enzyme inhibitors by immobilizing an enzyme (alkaline phosphatase) inside a capillary using 
magnetic beads. Enzyme inhibition assays were performed together with inhibitor separations in 
a single run. A fluorogenic substrate, AttoPhos, was included in the running buffer for the assays. 
Product was generated in the enzyme microreactor and detected by laser-induced fluorescence. 
Enzyme inhibition by each separated inhibitor species could be observed as a negative peak due 
to decreased product formation. Using this approach, the peak capacity for inhibitor separations 
was greatly enhanced compared to previous studies employing a method combing continuous 
engagement EMMA and transient engagement EMMA [50, 51]. 
To construct the on-column enzyme microreactor, alkaline phosphatase-coated 
superparamagnetic beads were eletrophoretically injected into the capillary and then transported 
by electrophoresis to the immobilizing magnet(s) at the downstream end of the capillary before 
the detection window. Two different magnet configurations, a single B442 magnet and a pair of 
D24 magnets, were used in this study. In both configurations, the magnetic field was sufficiently 
strong that magnetic beads were held in place successfully inside the capillary. The one-magnet 
configuration provided a higher peak capacity for separations of enzyme inhibitors. Therefore, 
the use of one-magnet configuration was preferred. A significant advantage of the approach for 
enzyme microreactor construction developed in this thesis is that the capillary can be reused by 
simply rinsing out the magnetic beads using a manual syringe pump. 
The goal of this study was to increase the peak capacity (nc) for inhibitor separations relative 




the applied field strength and bead injection time on peak capacity were investigated. Generally, 
the peak capacity decreased with increasing field strength for both magnet configurations. 
Considering both peak capacity and time required for electrophoretic separation, a field strength 
of 200 V/cm with nc ≈ 20 was chosen for later experiments. The bead injection time determines 
the number of alkaline phosphatase-coated magnetic beads injected and the length of the 
resulting bead plug. For alkaline phosphatase inhibition assays with arsenate (reversible, 
competitive inhibitor), the peak capacity first decreased rapidly as the bead injection time 
increased from 15 to 30 s. The peak capacity then increased slowly when bead injection time was 
increased further. Moreover, the S/N of arsenate inhibition peak did not change significantly for 
different bead injection times. For inhibition assays with theophylline (reversible, 
noncompetitive inhibitor), changing bead injection time had less of an effect on the peak 
capacity compared to arsenate. The S/N of theophylline inhibition peak was low with bead 
injection time of 3.0 s, and then increased by approximately a factor of 2 when the bead injection 
time was increased to 15 s. At longer bead injection times, the S/N ratio was relatively stable. 
Considering both the peak capacity and S/N, a magnetic bead injection time of 15.0 s was used 
for later experiments (nc ≈ 20). 
The effect of inhibitor concentration on inhibition peak width at half maximum (w1/2) also 
was studied. For inhibition assays with arsenate and assays with theophylline, the inhibition peak 
width increased with inhibitor concentration. For heterogeneous assays with arsenate using both 
one-magnet and two-magnet enzyme microreactors, the inhibition peak width increased by more 
than a factor of 20. For heterogeneous assays with theophylline using both enzyme microreactors 




increased by a factor of 6. Moreover, at all theophylline concentrations, the inhibition peak width 
for heterogeneous assays was 40-110% larger than that for homogeneous assays. 
A separation of five reversible inhibitors of alkaline phosphatase (theophylline, vanadate, 
arsenate, L-tryptophan and tungstate) was demonstrated using both the one and two-magnet 
enzyme microreactors. The inhibitors were separated by capillary electrophoresis before 
reaching the enzyme microreactor. All of the five inhibitors were baseline resolved within 30 
min. A peak capacity (nc) of 22 was obtained. The high separation efficiency of capillary 
electrophoresis provides this method the potential to screen enzyme inhibitors in a complex 
mixture. 
Homogeneous inhibition assays of alkaline phosphatase with a mixture of the five inhibitors 
also were carried out using a method developed previously in our lab [50, 51] which combines 
continuous engagement EMMA and transient engagement EMMA. Using this EMMA method, 
at most three inhibition peaks could be observed. The peak capacity for this method was shown 
to be very limited compared to our new approach using enzyme microreactors with magnetic 
beads.  
3.2 Future Studies 
Future studies based on the research in this thesis will focus on developing other novel 
approaches for separations of mixtures of enzyme inhibitors using on-line enzyme inhibition 
assays based on CE. Priority will still be placed on increasing the peak capacity for inhibitor 
separations. In preliminary work, an approach of carrying out temperature-controlled enzyme-
catalyzed reactions in a capillary was employed for enzyme inhibitor separations. The idea was 
to separate enzyme inhibitors when the enzyme activity was suppressed at a very low 




enzyme-catalyzed reaction at a high temperature. Two enzymes, alkaline phosphatase and 
horseradish peroxidase, were used in this approach, but the difference of enzyme activity at 
different temperatures was not great enough for this approach to succeed. 
One promising strategy for performing CE separations of enzyme inhibitors together with 
enzyme inhibition assays is to use liposomes to encapsulate substrate or enzyme. In this 
approach the capillary would be filled first with enzyme and its fluorogenic substrate which will 
be contained in liposomes. The interaction between enzyme and substrate would be blocked by 
the lipid membrane. A zone of inhibitor mixtures would be injected into the capillary. Inhibitors 
would be separated electrophoretically. After the separations of inhibitors, free substrate would 
be released from liposomes in the capillary by photolysis or electrochemical reactions to develop 
the enzyme-catalyzed reaction. Product generation would be observed as a constant fluorescence 
signal. Separated inhibitors would interact with the enzyme-substrate complex, and their 
respective negative peaks would be detected. Preliminary work to synthesize photolabile 
liposomes was carried out but not completed. 
Another approach for performing inhibitor separations and enzyme inhibition assays by CE 
would be using caged compounds. This approach is similar to the approach using liposomes in 
that the enzyme-catalyzed reaction is first blocked and then triggered to occur by an external 
stimulation. In this approach, enzyme substrate or cofactor would be modified chemically with a 
photolabile protecting group. Inhibitor mixtures would be separated first in a capillary filled with 
enzyme and substrate or cofactor which is protected by the caging group. Upon photolysis in the 
capillary, the protecting group of the caged enzyme substrate or cofactor would be removed to 
develop the enzyme-catalyzed reaction. Separated inhibitors would be detected as individual 
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